University of Nottingham
Translational Cancer Research
Within this research group, there are active research programmes in the development of cancer vaccines and identifying markers that indicate the prognosis for treatment of a variety of tumours (Durrant and Patel); profiling of intestinal adenomas (Ilyas); an internationally renowned breast cancer pathology research programme (Ellis); and mechanisms of apoptosis and chemo-resistance and an haemopoietic stem-cell transplantation programme (Russell).
Applicants for PhD programmes are generally required to hold an Honours degree at 2.1 level or above (or international equivalent) in an appropriate subject; candidates are generally required to submit a research proposal with their applications; International English Language Testing System (IELTS) [Academic version] 6.0 with no less than 5 in any one element; Test of English as a Foreign Language (TOEFL): Paper version: 550 with a minimum of 4.0 in the Test of Written English (TWE); Internet-based version:79 with no less than 17 in any one element.
|Qualification||Study mode||Fee||Course duration|
|PhD||Full-time||£ 3,980 per Academic year (home fees)||3 years|
|PhD||Full-time||£ 17,340 per Academic year (overseas fees)||3 years|
|Campus name||Town||Postcode||Region||Main campus||Campus||Partner|
|University Park Campus||Nottingham||NG7 2RJ||East Midlands|
Postgraduate Enquiries Team
0115 951 5559